GR
Grace Therapeutics, Inc. (GRCE)
NASDAQ·Healthcare·Biotechnology
$1.86
—
Mkt Cap $55.53M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+115.1%
Consensus $4.00 vs current $1.86
NASDAQ·Healthcare·Biotechnology
$1.86
—
Mkt Cap $55.53M
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
+115.1%
Consensus $4.00 vs current $1.86